ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,002,616 | -35.1% | 4,359,202 | 0.0% | 0.00% | – |
| Q1 2023 | $1,544,901 | +10.4% | 4,359,202 | 0.0% | 0.00% | – |
| Q4 2022 | $1,398,868 | -56.0% | 4,359,202 | +0.1% | 0.00% | – |
| Q3 2022 | $3,180,000 | -18.7% | 4,356,702 | +0.2% | 0.00% | – |
| Q2 2022 | $3,911,000 | -34.2% | 4,346,530 | +9.0% | 0.00% | – |
| Q1 2022 | $5,940,000 | -29.7% | 3,986,270 | +2.3% | 0.00% | – |
| Q4 2021 | $8,454,000 | -38.7% | 3,895,736 | +0.5% | 0.00% | – |
| Q3 2021 | $13,799,000 | -38.5% | 3,875,977 | -0.8% | 0.00% | -100.0% |
| Q2 2021 | $22,438,000 | +15.1% | 3,909,046 | +4.1% | 0.00% | 0.0% |
| Q1 2021 | $19,495,000 | +201.5% | 3,756,257 | +38.8% | 0.00% | – |
| Q4 2020 | $6,467,000 | +142.3% | 2,705,715 | +40.9% | 0.00% | – |
| Q3 2020 | $2,669,000 | -23.0% | 1,920,282 | +5.9% | 0.00% | – |
| Q2 2020 | $3,464,000 | -0.6% | 1,813,492 | +27.5% | 0.00% | – |
| Q1 2020 | $3,484,000 | +19.0% | 1,422,052 | +9.3% | 0.00% | – |
| Q4 2019 | $2,928,000 | +6.9% | 1,301,397 | -0.3% | 0.00% | – |
| Q3 2019 | $2,740,000 | -22.2% | 1,304,807 | -7.7% | 0.00% | – |
| Q2 2019 | $3,521,000 | -29.1% | 1,413,924 | +12.4% | 0.00% | – |
| Q1 2019 | $4,967,000 | +956.8% | 1,257,419 | +269.0% | 0.00% | – |
| Q4 2018 | $470,000 | -54.2% | 340,724 | -17.0% | 0.00% | – |
| Q3 2018 | $1,026,000 | +1.9% | 410,275 | +3.8% | 0.00% | – |
| Q2 2018 | $1,007,000 | +34.8% | 395,160 | +11.1% | 0.00% | – |
| Q1 2018 | $747,000 | -55.0% | 355,533 | -0.4% | 0.00% | – |
| Q4 2017 | $1,659,000 | +64.3% | 356,881 | +166.8% | 0.00% | – |
| Q3 2017 | $1,010,000 | +78.8% | 133,747 | +23.1% | 0.00% | – |
| Q2 2017 | $565,000 | -3.3% | 108,670 | +11.1% | 0.00% | – |
| Q1 2017 | $584,000 | -14.5% | 97,778 | +0.9% | 0.00% | – |
| Q4 2016 | $683,000 | +47.5% | 96,878 | +5.4% | 0.00% | – |
| Q3 2016 | $463,000 | +46.1% | 91,878 | +3.3% | 0.00% | – |
| Q2 2016 | $317,000 | -27.8% | 88,978 | -6.5% | 0.00% | – |
| Q1 2016 | $439,000 | – | 95,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |